Effects of Psychoactive Chemicals on Commercial Driver Health and Performance: Stimulants, Hypnotics, Nutritional, and Other Supplements (2011)

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

112 Aaronson, D.W., “Effects of Terefenadine on Psychomotor Performance: An Overview,” Drug Safety, Vol. 8, 1993, pp. 321–330. Adelsberg, B.R., “Sedation and Performance Issues in the Treatment of Allergic Conditions,” Archives of Internal Medicine, Vol. 157, 1997, pp. 494–500. Ahasan, R., J. Lewko, D. Campbell, and A. Salmoni, “Adapta- tion to Night Shifts and Synchronization Processes of Night Workers,” Journal of Physiological Anthropology Applica- tions to Human Science, Vol. 8, No. 20, 2001, pp. 215–226. Akerstedt, T., “Searching for the Countermeasure of Night- shift Sleepiness,” Editorial commentary on Schweitzer et al. study of naps and caffeine, Sleep, Vol. 29, No. 1, 2006, pp. 39–50. Alvarez, F.J., “Warfarin, Medicinal Drugs and Road Traffic Accidents,” British Journal of Clinical Pharmacology, Vol. 62, No. 5, 2006, pp. 627–628. Alvarez, F.J. and M.C. Del Rio, “Medicinal Drugs and Driv- ing: From Research to Clinical Practice,” Trends in Phar- macological Sciences, Vol. 23, No. 9, 2002, pp. 441–443. Amendola, C.A., J.D.E. Gabrieli, and H.R. Lieberman, “Caffeine’s Effects on Performance and Mood Are Inde- pendent of Age and Gender,” Nutritional Neuroscience, Vol. 1, 1998, pp. 269–280. Arendt, J.T., “Melatonin Characteristics, Concerns, and Prospects,” Journal of Biological Rhythms, Vol. 20, 2005, pp. 291–303. Arendt, J.T. and D.J. Skene, “Melatonin as a Chronobiotic,” Sleep Medicine Review, Vol. 9, 2005, pp. 25–39. Baird, J.A., P.K.L. Coles, and A.N. Nicholson, “Human Fac- tors and Air Operations in the South Atlantic Campaign,” Journal of the Royal Society of Medicine, Vol. 76, 1983, pp. 933–937. Barbanoj, M.J., et al., “Evaluation of the Cognitive, Psy- chomotor and Pharmacokinetic Profiles of Rupatadine, Hydroxyzine and Cetirizine, in Combination with Alcohol, in Healthy Volunteers,” Human Psychopharmacology, Vol. 21, 2006, pp. 13–26. Barbone, F., et al., “Association of Road-traffic Accidents with Benzodiazepine Use,” Lancet, Vol. 352, 1998, pp. 1331–1336. Barger, L.K., K.P. Wright, R.L. Hughes, and C.A. Czeisler, “Daily Exercise Facilitates Phase Delays of Circadian Melatonin Rhythm in Very Dim Light,” American Journal of Physiological Regulation and Integration of Comparative Physiology, Vol. 286, 2004, pp. R1077–R1084. Bartholini, G., “Growing Aspects of Hypnotic Drugs,” In: Imidazopyridines in Sleep Disorders, J.P. Sauvanet, S.Z. Kanger, and P.L. Morselli, Eds., Raven Press, New York, N.Y., 1988, pp. 1–9. Bassit, R.A., L.A. Sawada, R.F.P. Bacurau, F. Navarro, and L.F.B.P. Costa Rosa, “The Effect of BCAA Supple- mentation Upon the Immune Response of Triathletes,” Medical Science and Sports Exercise, Vol. 32, No. 7, 2000, pp. 1214–1219. Batejat, D.M. and D.P. Lagarde, “Naps and Modafinil as Countermeasures for the Effects of Sleep Deprivation on Cognitive Performance,” Aviation, Space, and Environ- mental Medicine, Vol. 70, No. 5, 1999, pp. 493–498. Bell, D.G., I. Jacobs, and J. Zamecnik, “Effects of Caffeine, Ephedrine and Their Combination on Time to Exhaustion During High-intensity Exercise,” European Journal of Applied Physiology, Vol. 77, 1998, pp. 427–433. Bell, D.G., I. Jacobs, and K. Ellerington, “Caffeine and Ephedrine Ingestion: Effect on Anaerobic Performance,” Medical Science and Sports Exercise, Vol. 33, 2001, pp. 1399–1403. Bell, D.G., T.M. McLellan, and C.M. Sabiston, “Effects of Ingesting Caffeine and Ephedrine on 10km Run Perfor- mance,” Medical Science Sports and Exercise, Vol. 34, No. 2, 2002, pp. 344–349. Bendich, A. and L. Machlin, “Safety of Oral Intake of Vitamin E,” American Journal of Clinical Nutrition, Vol. 48, 1988, pp. 612–619. Benoit, O., M. Clodore, N. Touron, and E. Pailhous, “Effects of CRL 40476 (central alpha stimulant: modafinil) on Sleepiness in Normal Sleep Deprived and in Symp- tomatic Subjects,” In: Proceedings of the Meeting of the 8th European Congress of Sleep Research, Szeged, Hungary, Sep. 1986. Benoit, O., M. Clodore, N. Touron, and E. Pailhous, “Effects of Modafinil on Sleepiness in Normal Sleep Deprived and Symptomatic Subjects,” In: Proceedings of the 5th Inter- national Congress of Sleep Research, Copenghagen, Denmark, 1987. Betts T., D. Markman, S. Debenham, D. Mortiboy, and T. McKevitt, “Effects of Two Antihistamine Drugs on Actual Driving Performance,” British Medical Journal (Clinical Research Edition), Vol. 288, 1984, pp. 281–282. Blois, R., J. Gaillard, P. Attali, and J. Coqueline, “Effect of Zolpidem on Sleep in Healthy Subjects: A Placebo Controlled Trial with Polysomnographic Recordings,” Clinical Therapy, Vol. 13, 1993, pp. 797–809. Blomberg, R.A., R.C. Peck, H. Moskowitz, M. Burns, and D. Fiorentino, “Crash Risk of Alcohol Involved Driving: A Case-control Study,” Dunlap and Associates, Inc., Stamford, Conn., 2005 [Online]. Available: www.icadts.org. Blumenthal, M., A. Goldberg, and J. Brinckmann, “Herbal Medicine: Expanded Commission E Monographs,” Inte- grative Medicine Communications, 2000, pp. 226–229. APPENDIX E Bibliography of Additional Readings

113 Bolla, K.I., et al., “Sleep Disturbance in Heavy Marijuana Users,” Sleep, Vol. 31, No. 6, 2008, pp. 901–908. Bonati, M., R. Latini, F. Galletti, J.F. Young, G. Tognoni, and S. Garattini, “Caffeine Disposition after Oral Doses,” Clinical Pharmacology Therapy, Vol. 32, 1982, pp. 98–106. Bonnet, M.H. and D.L. Arand, “Caffeine Use as a Model of Acute and Chronic Insomnia,” Sleep, Vol. 15, 1992, pp. 526–536. Bonnet, M.H., T.J. Balkin, D.F. Dinges, T. Roehrs, N.L. Rogers, and N.J. Westensten, “The Use of Stimulants to Modify Performance During Sleep Loss: A Review by the Sleep Deprivation and Stimulant Task Force of the American Academy of Sleep Medicine,” Sleep, Vol. 28, No. 9, 2005, pp. 1163–1187. Boston University School of Medicine, Pharmacology and Experimental Therapeutics Department, “Definition of Half-life of Drugs. Glossary of Drug Related Terminology,” 2009 [Online]. Available: http://pharmamotioni.com.ar/ definition-of-half-life-of-drugs/. Botch, S.R., R.D. Johnson, A.K. Chaturvedi, and R.J. Lewis, Distribution of Oxycodone in Postmortem Fluids and Tis- sues, CAMI Technical Report No. DOT-FAA-AM-10-11, Civil Aerospace Medical Institute, Federal Aviation Admin- istration, Oklahoma City, Okla., 2010. Bramness, J.G., S. Skurtveit, and J. Morland, “Clinical Impairment of Benzodiazepines—Relation Between Benzo- diazepine Concentrations and Impairment in Apprehended Drivers,” Drug Alcohol Dependency, Vol. 68, 2002, pp. 131–141. Bricknell, M.C., “Sleep Manipulation Prior to Airborne Exercises,” Journal of Royal Army Medical Corps, Vol. 137, 1991, pp. 22–26. Browman, C.P. and M.M. Mitler, “Hypersomnia and the Perception of Sleep Wake States: Some Preliminary Findings,” Perceptual and Motor Skills, Vol. 66, 1988, pp. 463–470. Brunnauer, A., G. Laux, E. Geiger, M. Soyka, and H.J. Moller, “Antidepressants and Driving Ability: Results from a Clinical Study,” Journal of Clinical Psychiatry, Vol. 67, No. 11, 2006, pp. 1776–1781. Brzezinski, A., et al., “Effects of Exogenous Melatonin on Sleep: A Meta-analysis,” Sleep Medicine Review, Vol. 9, 2005, pp. 41–50. Bucci, L.R., “Nutritional Ergogenic Aids,” In: Nutrition in Exercise and Sport, J.F. Hickson and I. Wolinsky, Eds., CRC Press, London, U.K., 1989. Burgess, H.J., K.M. Sharkey, and C.I. Eastman, “Bright Light, Dark and Melatonin Can Promote Circadian Adaptation in Night Shift Workers,” Sleep Medicine Review, Vol. 6, 2002, pp. 407–420. Buysse, D.J., “Drugs Affecting Sleep, Sleepiness and Perfor- mance,” Chapter 10, In: Sleep, Sleepiness and Performance, T.H. Monk, Ed., John Wiley and Sons, Ltd., New York, N.Y., 1991, pp. 249–306. Caldwell, J.A., “Efficacy of Stimulants for Fatigue Manage- ment: The Effects of Provigil and Dexedrine on Sleep- deprived Aviators,” Transportation Research Part F: Traffic Psychology and Behaviour, Vol. 4, No. 1, 2001, pp. 19–37. Carlson, M. and R.D. Thompson, “Liquid Chromatographic Determination of Methylxanthines and Catechins in Herbal Preparations Containing Guarana,” Journal of AOAC International, Vol. 81, No. 4, 1998, pp. 691–697. Caufield, J.S. and H.J. Forbes, “Dietary Supplements Used in the Treatment of Depression, Anxiety, and Sleep Dis- orders,” Lippincotts Primary Care Practice, Vol. 3, No. 3, 1999, pp. 290–304. Childs, E. and H. DeWit, “Enhanced Mood and Psychomotor Performance by a Caffeine-containing Energy Capsule in Fatigued Individuals,” Experimental and Clinical Psycho- pharmacology, Vol. 16, No. 1, 2008, pp. 13–21. Christophersen, A.S., G. Ceder, J. Kristinsson, P. Lillsunde, and A. Steentoft, “Drugged Driving in the Nordic Countries: A Comparative Study Between Five Countries,” Forensic Science International, Vol. 106, 1999, pp. 173–190. Clark, J.F., “Creatine: A Review of Its Nutritional Applications in Sport,” Nutrition, Vol. 14, 1998, pp. 322–324. Comperatore, C.A., J.A. Caldwell, and J.L. Caldwell, Leader’s Guide to Crew Endurance: Instructional Brochure on Crew Work/Rest Scheduling, Circadian Rhythms, Fatigue, and Fatigue Countermeasures, USAARL Technical Report, U.S. Army Aeromedical Research Laboratory and the U.S. Army Safety Center, Fort Rucker, Ala., 1997. Cornum, K.G., R. Cornum, and W. Storm, “Use of Psycho- stimulants in Extended Flight Operations: A Desert Shield Experience,” In: NATO AGARD Conference Proceedings No. 579: Neurological Limitations of Aircraft Operations: Human Performance Implications, NATO Advisory Group for Aerospace Research and Development, Neuilly-sur- Seine, France, 1996, pp. 371–373. Cornum, R., J.A. Caldwell, and K.G. Cornum, “Stimulant Use in Extended Flight Operations,” Airpower Journal, Vol. 11, No. 1, 1997, pp. 53–58. Couper, F.J. and B.K. Logan [with F. Corbett, J. Huestis, and J.G. Ramaekers], Drugs and Human Performance Fact Sheets, NHTSA Technical Report, National Highway Trans- portation Safety Administration, Washington, D.C., 2004. Crouch, D.J., et al., “The Prevalence of Drugs and Alcohol in Fatally Injured Truck Drivers,” Journal of Forensic Science, Vol. 38, No. 6, 1993, pp. 1342–1353. Czeisler, C.A. and F.W. Turek, “Melatonin, Sleep and Cir- cadian Rhythms: Current Progress and Controversies,” Journal of Biological Rhythms, Vol. 12, 1997, pp. 685–708. Dagan, Y., T. Doljansky, and A. Green, “Body Mass Index as a First Line Screening Criterion for Detection of Excessive Daytime Sleepiness Among Professional Drivers,” Traffic Injury Prevention, Vol. 7, 2006, pp. 44–48. Dang, J.N., Statistical Analysis of Alcohol-related Driving Trends, 1982–2005, NHTSA Technical Report No. DOT- HS-810-942, National Highway Traffic Safety Adminis- tration, U.S. Department of Transportation, Washington, D.C., 2008. Davis, J.M., N.L. Alderson, and R.S. Welsh, “Serotonin and Central Nervous System Fatigue: Nutritional Considera- tions,” American Journal of Clinical Nutrition, Vol. 72, 2000, pp. 573S–578S.

DeGier, J.J., “Decision Support Tables for Psychotropic Medicines,” In: Alcohol, Drugs and Traffic Safety—T-97, Conference Proceedings, Vol. III, C. Mercier-Guyon, Ed., CERT, Annecy, France, 1997, pp. 1275–1282. DeGier, J.J., “Drugs and Driving Research: Application of Results by Drug Regulatory Authorities,” Human Psycho- pharmacology: Clinical and Experimental, Vol. 13, No. 52, 1998, pp. S133–S136. Diego, M.A., et al., “Aromatherapy Positively Affects Mood, EEG Patterns of Alertness and Math Computations,” Inter- national Journal of Neuroscience, Vol. 96, No. 3–4, 1998, pp. 217–224. Dijk, D-J., et al., “Sleep, Performance, Circadian Rhythms, and Light-Dark Cycles During Two Space Shuttle Flights,” American Journal of Physiology Regulatory Integrative Comparative Physiology, Vol. 281, 2001, pp. R1647–R1664. Drummer, O.H., et al., “The Involvement of Drugs in Drivers of Motor Vehicles Killed in Australian Road Traffic Crashes,” Accident Analysis and Prevention, Vol. 36, 2003, pp. 239–248. Drummer, O.H., et al., “The Incidence of Drugs in Drivers Killed in Australian Road Traffic Crashes,” Forensic Science International, Vol. 134, 2003, pp. 154–162. Eckhardt, M.J., et al., “Effects of Moderate Alcohol Consumption on the Central Nervous System,” Alcohol and Clinical Experimental Research, Vol. 22, 1998, pp. 998–1040. Elsbagh, S., D.E. Hartley, O. Ali, E.M. Williamson, and S.E. File, “Differential Cognitive Effects of Ginkgo Biloba After Acute and Chronic Treatment in Healthy Young Volunteers,” Psychopharmacology, Vol. 179, No. 2, 2005, pp. 437–446. Emonson, D.L. and R.D. Vanderbeek, “The Use of Amphet- amine in U.S. Air Force Tactical Operations During Desert Shield and Storm,” Aviation, Space and Environ- mental Medicine, Vol. 66, 1995, pp. 260–263. Engleman, H., W. Hirst, and N. Douglas, “Under Reporting of Sleepiness and Driving Impairment in Patients with Sleep Apnoea/Hypopneas Syndrome,” European Sleep Research, Vol. 6, 1997, pp. 272–275. Erman, M., A. Guiraud, V.N. Jolsh, and D. Lerner, “Zolpidem Extended-release 12.5 mg Associated with Improve- ments in Work Performance in a 6-Month Randomized, Placebo-controlled Trial,” Sleep, Vol. 31, No. 10, 2008, pp. 1371–1378. Farah, M.J., et al., “Neurocognitive Enhancement: What Can We Do and What Should We Do?” Nature Reviews Neuro- science, Vol. 5, 2004, pp. 421–425. Farell, P.M. and J.G. Bieri, “Megavitamin E Supplementation in Man,” American Journal of Clinical Nutrition, Vol. 28, 1985, pp. 1381–1386. Farrell, L.J., “The Effects of Drugs on Human Performance and Behavior,” Special issue, Forensic Science Review, Vol. 15, No. 1, 2003, pp. 1–74. Federal Highway Administration, Conference on Pulmonary/ Respiratory Disorders and Commercial Drivers, FHWA 114 Technical Report No. MC-91-004, FHWA, Washington, D.C., 1991. Federal Motor Carrier Safety Administration, Drug and Alcohol Testing Survey: FMCSA Analysis Brief, FMCSA Technical Report No. MCRT-00-013, Office of Research and Technology, Federal Motor Carrier Safety Administra- tion, U.S. Department of Transportation, Washington, D.C., Aug. 2000. Federal Motor Carrier Safety Administration [formerly FHWA Office of Motor Carriers], Neurology Guideline II, 1988 [Online]. Available: www.fmcsa.dot.gov. Flemmons, W.W., W.A. Whitelaw, R. Brant, and J.E. Remmers, “Likelihood Ratios for a Sleep Apnea Clinical Prediction Rule,” American Journal of Respiratory Critical Care Medicine, Vol. 150, 1994, pp. 1279–1285. Franks, H.M., V.R. Hensley, W.J. Hensley, G.A. Starner, and R.K. Teo, “The Relationship Between Alcohol Dosage and Performance Decrement in Humans,” Journal of Studies of Alcohol, Vol. 37, 1976, pp. 284–297. Fredholm, B.B., K. Battig, J. Holmen, A. Nehlig, and E.E. Zvartau, “Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use,” Pharmacological Review, Vol. 51, 1999, pp. 83–133. French, J., P. Boll, W. Storm, and P. Dowd, “Temazepam and Performance Following a Sleep Cycle Shift,” Annals of Review of Chronopharmacology, Vol. 7, 1990, pp. 41–44. Fugh-Berman, A., “Herb-Drug Interactions,” Lancet, Vol. 355, No. 9198, 2000, pp. 134–138. Gaster, B. and J. Holroyd, “St. John’s Wort for Depression: A Systematic Review,” Archives of Internal Medicine, Vol. 160, 2000, pp. 152–156. Geha, R.S. and E.O. Meltzer, “Desloratadine: A New, Non-sedating Oral Antihistamine,” Journal of Allergy and Clinical Immunology, Vol. 107, 2001, pp. 751–762. Gengo, F.M. and C. Gabos, “Antihistamines, Drowsiness, and Psychomotor Impairment: Central Nervous System Effect of Cetirizine,” Annals of Allergy, Vol. 59, 1987, pp. 53–57. Gengo, F.M. and C. Manning, “A Review of the Effects of Antihistamines on Mental Processes Related to Automobile Driving,” Journal of Allergy Clinical Immunology, Vol. 86, 1990, pp. 1034–1039. Gengo, F.M., J. Debronzo, A. Yurchak, S. Love, and J.K. Miller, “The Relative Antihistaminic and Psychomotor Effects of Hydroxyzine and Cetirizine,” Clinical Pharma- cology Therapy, Vol. 42, 1987, pp. 265–272. Gengo, F.M., C. Gabos, and L. Mechtler, “Quantitative Effects of Cetirizine and Diphenhydramine on Mental Performance Measured Using an Automobile Driving Simulator,” Annals of Allergy, Vol. 64, 1990, pp. 520–526. Ghelardini, C., N. Galeotti, G. Salvatore, and G. Mazzanti, “Local Anesthetic Activity of the Essential Oil of Lavan- dula Angustifolia,” Planta Medicine, Vol. 65, No. 8, 1999, pp. 700–703. Gilliland, K., R.E. Schlegel, and T.E. Nesthus, Workshift and Antihistamine Effects on Task Performance, FAA Technical Report No. DOT-FAA-AM-97-25, Federal Avia- tion Administration, U.S. Department of Transportation, Washington, D.C., 1997.

115 Gillingham, R.L., A.A. Keefe, and P. Tikuisis, “Acute Caffeine Intake Before and After Fatiguing Exercise Improves Target Shooting Engagement Time,” Aviation, Space, and Envi- ronmental Medicine, Vol. 75, No. 10, 2004, pp. 865–871. Gottselig, J.M., M. Adam, J.V. Retey, R. Khatami, P. Acher- man, and H.P. Landolt, “Random Number Generation During Sleep Deprivation: Effects of Caffeine on Response Maintenance and Stereotypy,” Journal of Sleep Research, Vol. 15, 2006, pp. 31–40. Graf, O., “Increase of Efficiency by Means of Pharmaceutics (stimulants),” Chapter 11, In: German Aviation Medicine in World War II (Vol. II), U.S. Army Air Corps, Department of Army, 1946. Greenblatt, D.J., “Pharmacology of Benzodiazepine Hyp- notics,” Journal of Clinical Psychiatry, Vol. 53 (Supple- ment 6), 1992, pp. 7–13. Greenblatt, D.J., G. Zammit, J. Harmatz, and E. Legangneux, “Zolpidem Modified-release Demonstrates Sustained and Greater Pharmacodynamic Effects from 3 to 6 Hours Post Dose as Compared with Standard Zolpidem in Healthy Adult Subjects [abstract],” Sleep, Vol. 28 (Supplement), 2005, p. A245. Gustavsen, I., J. Morland, and J.G. Bramness, “Impairment Related to Blood Amphetamine and/or Methamphetamine Concentrations in Suspected Drugged Drivers,” Accident and Analytical Prevention, Vol. 38, 2006, pp. 490–495. Gyllenhaal, C., S.L. Merrit, S.D. Peterson, K.I. Block, and T. Gochenour, “Efficacy and Safety of Herbal Stimulants and Sedatives in Sleep Disorders,” Sleep Medicine Reviews, Vol. 4, No. 2, 2000, pp. 1–24. Hadley, S. and J.J. Petry, “Valerian,” American Family Physician, Vol. 67, 2003, pp. 1755–1758. Haffner, J.F.W., et al., “Mental and Psychomotor Effects of Diazepam and Ethanol,” Acta Pharmacolical Toxicology, Vol. 32, 1973, pp. 161–178. Hall, W. and N. Solowij, “Adverse Effects of Cannabis,” Lancet, Vol. 352, 1998, pp. 1611–1616. Halliday, R., E. Callaway, H. Naylor, P. Gratzinger, and R. Prael, “The Effects of Stimulant Drugs on Information Processing in Elderly Adults,” Journal of Gerontology, Vol. 41, 1986, pp. 748–757. Halliday, R., K. Gregory, H. Naylor, E. Callaway, and L. Yano, “Beyond Drug Effects and Dependent Variables: The Use of the Poisson–Erland Model to Assess the Effects of d-amphetamine on Information Processing,” Acta Psycho- logica, Vol. 73, 1990, pp. 35–54. Hanks, G.W., W.M. O’Neill, P. Simpson, and K.A. Wesnes, “The Cognitive and Psychomotor Effects of Opioid Anal- gesics. II: A Randomized Controlled Trial of Single Doses of Morphine, Lorazepam and Placebo in Healthy Subjects,” European Journal of Clinical Pharmacology, Vol. 48, 1995, pp. 455–460. Hardy, M. and M.D. Kirk-Smith, “Replacement of Drug Treatment for Insomnia by Ambient Odor,” Lancet, Vol. 346, 1995, p. 701. Hart, C.L., M. Haney, S.K. Vosburg, S.D. Comer, E. Gun- derspm, and R.W. Foltom, “Modafinial Attenuates Dis- ruptions in Cognitive Performance During Simulated Night-shift Work,” Neuropsychopharmacology, Vol. 31, 2006, pp. 1526–1536. Hartman, E., M. Hecht-Orzack, and R. Branconnier, “Sleep Deprivation Deficits and Their Reversal by d- and l- amphetamine,” Psychopharmacology, Vol. 53, No. 2, 1977, pp. 185–189. Haskell, C.F., D.O. Kennedy, K.A. Wesnes, and A.B. Scholey, “Cognitive and Mood Improvements of Caffeine in Habitual Consumers and Habitual Non-consumers of Caffeine,” Psychopharmacology, Vol. 179, No. 4, 2005, pp. 813–825. Hausken, A.M., S. Skurtveit, and A.S. Christophersen, “Mortality Among Subjects Previously Apprehended for Driving Under the Influence of Traffic-hazardous Medici- nal Drugs,” Drug Alcohol Dependence, Vol. 79, 2005, pp. 423–429. Haward, L.R.C., “Effects of Sodium Diphenylhydantoinate and Pemoline upon Concentration: A Comparative Study,” In Drugs and Cerebral Function, W.L. Smith, Ed., Charles C. Thomas, Springfield, Ill., 1970, pp. 103–120. Hemmeter, U., M. Muller, R. Bischof, B. Annen, and E. Holsboer-Trachsler, “Effect of Zopiclone and Tema- zepam on Sleep EEG Parameters, Psychomotor and Mem- ory Functions in Healthy Elderly Volunteers,” Psycho- pharmacology, Vol. 147, No. 4, 1999, pp. 384–396. Herbert, E.W., S. Gelfand, L.D. Clark, and D.M. Gelfand, “Magnesium Pemoline: Stimulant Effects on Performance of Fatigued Men,” Clinical Pharmacological Therapy, Vol. 9, No. 5, 1968, pp. 578–581. Higgins, S.T., C.R. Rush, J.R. Hughes, W.K. Bickel, M. Lynn, and M.A. Capeless, “Effect of Cocaine and Alcohol, Alone and in Combination on Human Learning and Performance,” Journal of Experimental Analysis and Behavior, Vol. 58, 1992, pp. 87–105. Hindmarch, I., J.S. Kerr, and N. Sherwood, “The Effects of Alcohol and Other Drugs on Psychomotor Performance and Cognitive Function,” Alcohol and Alcoholism, Vol. 26, No. 1, 1991, pp. 71–79. Hindmarch, I., Z. Shamsi, N. Stanley, and D.B. Fair- weather, “A Double-blind, Placebo-controlled Investi- gation of the Effects of Fexofenadine, Loratadine and Promethazine on Cognitive and Psychomotor Function,” British Journal of Clinical Pharmacology, Vol. 48, 1998, pp. 200–206. Hindmarch, I., S. Johnson, R. Meadows, T. Kirkpatrick, and Z. Shamsi, “The Acute and Sub-chronic Effects of Levo- cetirizine, Cetirizine, Loratadine, Promethazine and Placebo on Cognitive Function, Psychomotor Performance, and Weal and Flare,” Current Medical Opinion, Vol. 17, 2001, pp. 241–255. Hindmarch, J. and Z. Shamsi, “Antihistamines: Models to Assess Sedative Properties, Assessment of Sedation, Safety and Other Side-effects,” Clinical and Experimental Allergy, Vol. 29, 1999, pp. 133–142. Holbrook, A.M., R. Crowther, A. Lotter, C. Cheng, and D. King, “The Diagnosis and Management of Insomnia in Clinical Practice: A Practical Evidence-based Approach,” Canadian Medical Association Journal, Vol. 162, 2000, pp. 216–220.

Holbrook, A.M., R. Crowthere, A. Lotter, C. Cheng, and D. King, “Meta-analysis of Benzodiazepine Use in the Treatment of Insomnia,” Canadian Medical Association Journal, Vol. 162, 2000, pp. 225–233. Horne, J.A. and B.S. Shackell, “Slow Wave Sleep Elevations After Body Heating: Proximity to Sleep and Effects of Aspirin,” Sleep, Vol. 10, No. 4, 1987, pp. 383–392. Hou, R.H., R.W. Langley, E. Szabadi, and C.M. Bradshaw, “Comparison of Diphenhydramine and Modafinil on Arousal and Autonomic Functions in Healthy Volunteers,” Journal of Psychompharmacology, Vol. 21, No. 6, 2007, pp. 567–578. Howard, M.E., M.L. Jackson, G.A. Kennedy, P. Swann, M. Barnes, and R.J. Pierce, “The Interactive Effects of Extended Wakefulness and Low-dose Alcohol on Simulated Driving and Vigilance,” Sleep, Vol. 30, No. 10, 2007, pp. 1334–1340. Huck, N.O., S.A. McBride, A.P. Kendall, N.L. Grugle, and W.D.S. Killgore, “The Effects of Modafinil, Caffeine, and Dextroamphetamine on Judgments of Simple versus Complex Emotional Expressions Following Sleep Depri- vation,” International Journal of Neuroscience, Vol. 118, 2008, pp. 487–502. Hughes, F.W. and R.B. Forney, “Comparative Effects of Three Antihistamines and Ethanol on Mental and Motor Performance,” Clinical Pharmacology Therapy, Vol. 5, 1964, pp. 414, 421. Hunter, M.D., V. Ganesan, I.D. Wilkinson, and S.A. Spence, “Impact of Modafinil on Prefrontal Executive Function in Schizophrenia,” American Journal of Psychiatry, Vol. 163, 2006, pp. 2184–2186. Itil, T.M., E. Erlap, E. Tsambis, K.Z. Itil, and U. Stein, “Central Nervous System Effect of Ginkgo Biloba, a Plant Extract,” American Journal of Therapeutics, Vol. 3, 1996, pp. 63–73. Johnson, B.A., N. Ait-Daoud, and L.T. Wells, “Effects of Isradipine, a Dihydropyridine-Class Calcium Channel Antagonist, on D-methamphetamine-Induced Cognitive and Physiological Changes in Humans,” Neuropsycho- pharmacology, Vol. 22, 2000, pp. 504–512. Judd, L.J., “The Therapeutic Use of Psychotropic Medications,” In: Harrison’s Principles of Internal Medicine, 11th ed., E. Braunwald, K.J. Isselbacher, R.G. Pertersdorf, J.D. Wilson, J.B. Martin, and A.S. Faucci, Eds., McGraw–Hill, New York, N.Y., 1987, pp. 2103–2105. Karoliina K., K.K. Ojaniemi, T.P. Lintonen, A.O. Impinen, P.M. Lillsunde, and A.I. Ostamo, “Trends in Driving Under the Influence of Drugs: A Register-based Study of DUID Suspects During 1977–2007,” Accident Analysis and Pre- vention, Vol. 41, No. 1, 2009, pp. 191–196. Kennedy, D.O., C.F. Haskell, P.L. Mauri, and A.B. Scholey, “Acute Cognitive Effects of Standardised Ginkgo Biloba Extract Complexed with Phosphatidyslerine,” Human Psychopharmacology, Vol. 22, No. 4, 2007, pp. 199–210. Kerr, B., H. Hill, and B. Coda, “Concentration-related Effects of Morphine on Cognition and Motor Control in Human Subjects,” Neuropsychopharmacology, Vol. 5, 1991, pp. 157–166. 116 Killgore, W.D.S., S.A. McBride, D.B. Kilgore, and T.J. Balkin, “The Effects of Caffeine, Dextroamphetamine, and Modafinil on Humor Appreciation During Sleep Depriva- tion,” Sleep, Vol. 29, No. 6, 2006, pp. 841–847. Killgore, W.D.S., E.L. Lipizzi, G.H. Kamimori, and T.J. Balkin, “Caffeine Effects on Risky Decision-making After 75 Hours of Sleep Deprivation,” Aviation, Space, and Envi- ronmental Medicine, Vol. 78, 2007, pp. 957–962. Killgore, W.D.S., A.E. Muckle, N.L. Grugle, D.B. Killgore, and T.J. Balkin, “Sex Differences in Cognitive Estimation During Sleep Deprivation: Effects of Stimulant Counter- measures,” International Journal of Neuroscience, Vol. 118, No. 11, 2008, pp. 1547–1557. Killgore, W.D.S., T.L. Rupp, N.L. Grugle, R.M. Reichardt, E.L. Lipizzi, and T.J. Balkin, “Effects of Dextroamphet- amine, Caffeine and Modafinil on Psychomotor Vigi- lance Test Performance After 44 Hour of Continuous Wakefulness,” Journal of Sleep Research, Vol. 17, 2008, pp. 309–321. King, D.S., G.A. Brown, M.D. Vukovich, R.L. Sharp, T.A. Reifenrath, and K.A. Parsons, “Effect of Oral and Ros- tenedione on Serum Testosterone, Strength, Lean Mass, Blood Lipids, and Liver Function During Resistance Train- ing in Young Men,” Journal of the American Medical Asso- ciation, Vol. 281, No. 21, 1999, pp. 2020–2028. Klein, K.E., “Prediction of Flight Safety Hazards from Drug Induced Performance Decrements with Alcohol as Reference Substance,” Aerospace Medicine, Vol. 43, 1972, pp. 1207–1214. Koppelstaettere, F., et al., “Does Caffeine Modulate Verbal Working Memory Processes? An fMRI Study,” Neuro- image, Vol. 39, 2008, pp. 492–499. Kreider, R.B., V. Miriel, and E. Bertun, “Amino Acid Supple- mentation and Exercise Performance,” Sports Medicine, Vol. 16, 1993, pp. 190–209. Krueger, G.P. and H. Babkoff, “Preface to the Special Issue: Stimulants to Ameliorate Sleep Loss During Sus- tained Operations,” Military Psychology, Vol. 4, 1992, pp. 189–190. Krueger, G.P., R.M. Brewster, V.R. Dick, R. Inderbitzen, and L. Staplin, “Synthesis on Health and Wellness Programs for Commercial Drivers,” CD-ROM, Proceedings of the 86th Annual Meeting of the Transportation Research Board, Washington, D.C., Jan. 21–25, 2007. Krüger, H.P., “Effects of Low Alcohol Dosages: A Review of the Literature,” In: Alcohol, Drugs and Traffic Safety— T92, Proceedings of the 12th International Conference on Alcohol, Drugs and Traffic Safety, H.D. Utselmann, G. Berghaus, and G. Kroj, Eds., Cologne, Germany, Oct. 1992. Krystal, A.D. and I. Ressler, “The Use of Valerian in Neuro- psychiatry,” CNS Spectrums, Vol. 6, 2001, pp. 841–847. Krystal, A.D., M. Erman, G.K. Zammit, C. Soubrane, and T. Roth, “Long-term Efficacy and Safety of Zolpidem Extended-release 12.5 mg, Administered 3 to 7 Nights per Week for 24 Weeks, In-patients with Chronic Primary Insomnia: A 6-month Randomized, Double-blind, Placebo-

117 controlled, Parallel-group, Multicenter Study,” Sleep, Vol. 31, No. 1, 2008, pp. 79–90. Kunkel, H., “EEG Profile of Three Different Extractions of Ginkgo Biloba,” Neuropsychobiology, Vol. 27, No. 1, 1993, pp. 40–45. Kunsman, G.W., J.E. Manno, M.A. Przekop, B.R. Manno, and C.M. Kunsman, “The Effects of Temazepam and Ethanol on Human Psychomotor Performance,” Euro- pean Journal of Clinical Pharmacology, Vol. 43, 1992, pp. 603–611. Lamers, C.T., M. Rizzo, A. Bechara, and J. Ramaekers, “Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non- drug Using Controls,” Transportation Research Record, Journal of the Transportation Research Board, No. 1969, Transportation Research Board of the National Academies, Washington, D.C., 2006, pp. 50–57. Landauer, A.A. and G. Milner, “Antihistamines, Alone and Together with Alcohol in Relation to Driving Safety,” Journal of Forensic Medicine, Vol. 18, 1971, pp. 127–139. Lebot, V., Kava: The Pacific Drug, Yale University Press, New Haven, Conn., 1988. Lee, I.S. and G.J. Lee, “Effects of Lavender Aromatherapy on Insomnia and Depression in Women College Students,” Taehan Kanho Hakhoe Chi, Vol. 36, No. 1, 2006, pp. 136–143. Leese, P., G. Maier, L. Vaickus, and E. Akylbekova, “Esopiclone: Pharmacokinetic and Pharmacodynamic Effects of a Novel Sedative Hypnotic After Daytime Admin- istration in Healthy Subjects” [abstract], Sleep, Vol. 25 (Supplement), 2002, p. A45. Lewy, A.J., J. Emens, A. Jackman, and K. Yuhas, “Circadian Uses of Melatonin in Humans,” Chronobiology Inter- national, Vol. 23, 2006, pp. 403–412. Lieberman, H.R., “Caffeine,” In: Factors Affecting Human Performance Vol. II: The Physical Environment, D. Jones and A. Smith, Eds., Academic Press, London, U.K., 1992. Lieberman, H.R., “The Effects of Ginseng, Ephedrine and Caffeine on Cognitive Performance, Mood and Energy,” Nutrition Reviews, Vol. 59, No. 4, 2001, pp. 91–102. Lieberman, H.R., “Nutrition, Brain Function and Cognitive Performance,” Appetite, Vol. 40, No. 3, 2003, pp. 245–254. Lieberman, H.R., B.J. Fine, J.L. Kobrick, and J.D.E. Gabrieli, Effects of Caffeine on Mental Performance and Mood: Implications for Aircrew Members. Nutriton Metabolic Disorders and Lifestyle of Aircrew, NATO Advisory Group for Aerospace Research and Development Conference Pro- ceedings, SPS Ltd., London, U.K., 1993, pp. 30-1 to 30-10. Lieberman, H.R., C.M. Falco, and S.S. Slade, “Carbohy- drate Administration During a Day of Sustained Aerobic Activity Improves Vigilance, as Assessed by a Novel Ambulatory Monitoring Device, and Mood,” The Ameri- can Journal of Clinical Nutrition, Vol. 76, No. 1, 2002, pp. 120–127. Lieberman, H.R., W.J. Tharion, B. Shukitt-Hale, K.L. Speckman, and R. Tulley, “Effects of Caffeine, Sleep Loss, and Stress on Cognitive Performance and Mood During U.S. Navy Seal Training,” Psychopharmacology, Vol. 164, No. 3, 2002, pp. 250–261. Liguori, A. and J.H. Robinson, “Caffeine Antagonism of Alcohol-induced Driving Impairment,” Drug and Alcohol Dependence, Vol. 63, No. 2, 2001, pp. 123–129. Linnoila, M. and M.J. Mattila, “Drug Interaction on Psycho- motor Skills Related to Driving: Diazepam and Alcohol,” European Journal of Clinical Pharmacology, Vol. 5, 1973, pp. 186–194. Linnoila, M., I. Saario, and M. Maki, “Effect of Treatment with Diazepam or Lithium and Alcohol on Psychomotor Skills Related to Driving,” European Journal of Clinical Pharmacology, Vol. 7, 1974, pp. 337–342. Linnoila, M., I. Saario, J. Okoniemi, R. Liljequist, J.J. Himberg, and M. Maki, “Effect of Two Weeks Treatment with Cholordiazepoxide or Flupenthixole Alone or in Com- bination with Alcohol, on Psychomotor Skills Related to Driving,” Arzneim. Forsch., Vol. 25, 1975, pp. 1088–1092. Lisper, H.O., H. Laurell, and J. Van Loon, “Relation Between Time to Falling Asleep Behind the Wheel on a Closed Track and Changes in Subsidiary RT During Prolonged Driving on a Motorway,” Ergonomics, Vol. 29, 1986, pp. 445–453. Lorist, M.M. and M. Tops, “Caffeine, Fatigue, and Cognition,” Brain Cognition, Vol. 53, No. 1, 2003, pp. 82–94. Lu, B., R. Budhiraja, and S. Parthasarathy, “Sedating Medica- tions and Undiagnosed Obstructive Sleep Apnea: Physician Determinants and Patient Consequences,” Journal of Clin- ical Sleep Medicine, Vol. 1, No. 4, 2005, pp. 367–371. Mabbott, N.A. and L.R. Hartley, “Patterns of Stimulant Drug Use on Western Australian Heavy Transport Routes,” Transport Research Record, Part F, Vol. 2, 1999, pp. 115–130. MacLean, D.A., T.E. Graham, and B. Saltin, “Stimulation of Muscle Ammonia Production During Exercise Fol- lowing Branched-chain Amino Acid Supplementation in Humans,” Journal of Physiology, Vol. 493, No. 3, 1998, pp. 909–922. Mann, R.D., G.L. Pearce, N. Dunn, and S. Shakir, “Sedation with ‘Non-sedating’ Antihistamines: Four Prescription- event Monitoring Studies in General Practice,” British Medical Journal, Vol. 320, 2000, pp. 1184–1186. Mattay, V.S., et al., “Dextroamphetamine Enhances ‘Neural Network-specific’ Physiological Signals: A Positron- emission Tomography rCBF Study,” Journal of Neuro- science, Vol. 16, 1996, pp. 4816–4822. Mattay, V.S., et al., “Effects of Dextroamphetamine on Cog- nitive Performance and Cortical Activation,” Neuroimage, Vol. 12, No. 3, 2000, pp. 268–275. Mattila, M.J. and I. Paakkari, “Variations Among Non-sedating Antihistamines: Are There Real Differences?” European Journal of Clinical Pharmacology, Vol. 55, 1999, pp. 85–93. Meltzer, E.O., “Performance Effects of Antihistamines,” Journal of Allergy and Clinical Immunology, Vol. 86, 1990, pp. 613–619. Meltzer, E.O., “Comparative Safety of H1 Antihistamines,” Annals of Allergy, Vol. 67, 1991, pp. 625–633.

Mendelson, W.B., “Clinical Neuropharmacology of Sleep,” Neurology and Clinical Neurophysiology, Vol. 8, 1990, pp. 153–160. Mendelson, W.B., “Neuropharmacology of Sleep Induction by Benzodiazepines,” Critical Review of Neurobiology, Vol. 6, 1992, pp. 221–232. Mendelson, W.B., “A Critical Evaluation of the Hypnotic Efficacy of Melatonin,” Sleep, Vol. 20, 1997, pp. 916–919. Mendelsohn, A.B., S.H. Belle, G.P. Stoehr, and M. Ganguli, “Use of Antioxidant Supplements and Its Association with Cognitive Function in a Rural Elderly Cohort: The MOVIES Project, Monongahela Valley Independent Elders Survey,” American Journal of Epidemiology, Vol. 148, No. 1, 1988, pp. 38–44. Menkes, D.B., “Hypnosedatives and Anxiolytics,” In: Meyler’s Side Effects of Drugs, 14th ed., M.N.G. Dukes and J.K. Aronson, Eds., Elsevier Science, Amsterdam, the Nether- lands, 2000, pp. 121–138. Mignot, E., “Narcolepsy: Pharmacology, Pathophysiology, and Genetics,” Chapter 64, In: Principles and Practice of Sleep Medicine, 4th ed., M.H. Kryger, T. Roth, and W.C. Dement, Eds., Elsevier Saunders, Philadelphia, Pa., 2005, pp. 761–779. Mitler, M.M., et al., “Hypnotic Efficacy of Temazepam: A Long-term Sleep Laboratory Evaluation,” British Journal of Clinical Pharmacology, Vol. 8, 1979, pp. 63S–68S. Mittleman, K.D., M.R. Ricci, and S.P. Bailey, “Branched- chain Amino Acids Prolong Exercise During Heat Stress in Men and Women,” Medical Science and Sports Exercise, Vol. 30, No. 1, 1998, pp. 83–91. Mo, Q., S.F. Lu, and N.G. Simon, “Dehydroepiandrosterone and Its Metabolites: Differential Effects on Androgen Recepter Trafficking and Transcriptional Activity,” Journal of Steroid Biochemistry and Molecular Biology, Vol. 99, No. 1, 2006, pp. 50–58. Molina, V.A. and D.A. Orsingher, “Effects of Mg-Pemoline on the Central Catecholaminergic System,” Archives Inter- nationales de Pharmacodynamie et de Therapie, Vol. 251, 1981, pp. 66–79. Montgomery, L.C. and P.A. Deuster, “Ingestion of an Anti- histamine Does Not Affect Exercise Performance,” Medical Science and Sports Exercise, Vol. 24, 1992, pp. 383–388. Montgomery, L.C. and P.A. Deuster, “Effects of Antihistamine Medication on Exercise Performance: Implications for Sportspeople,” Sports Medicine, Vol. 15, 1993, pp. 179–195. Monti, J.M., “Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics,” Current Medical Chemical Central Nervous System Agents, Vol. 4, 2004, pp. 119–137. Morland, J., “Driving Under the Influence of Non-alcoholic Drugs,” Forensic Science Review, Vol. 12, 2000, pp. 79–105. Morris, A., I. Jacobs, T.M. McLellan, A. Klugerman, L.C. Wang, and J. Zamecnik, “No Ergogenic Effect of Ginseng Ingestion,” International Journal of Sports Nutrition, Vol. 6, 1996, pp. 263–271. 118 Moser, I., K.J. Huther, J. Koch-Weser, and P.V. Lundt, “Effects of Terfenadine and Diphenhydramine Alone or in Combination with Diazepam or Alcohol on Psychomotor Performance and Subjective Feelings,” European Journal of Clinical Pharmacology, Vol. 14, 1978, pp. 417–423. Moskowitz, H. and C.J. Wilkinson, “Antihistamines and Driving-related Behaviour: A Review of the Evidence for Impairment,” U.S. Department of Transportation Techni- cal Report, U.S.DOT, Washington, D.C., 2004 Motomura, N., A. Sakurai, and Y. Yotsuya, “Reduction of Mental Stress with Lavender Odorant,” Perceptual and Motor Skills, Vol. 93, No. 3, 2001, pp. 713–718. Movig, K.L., et al., “Psychoactive Substance Use and the Risk of Motor Vehicle Accidents,” Accident Analysis Preview, Vol. 36, 2004, pp. 631–636. Muehlbach, M.J. and J.K. Walsh, “The Effects of Caffeine on Simulated Night-shift Work and Subsequent Daytime Sleep,” Sleep, Vol. 18, 1995, pp. 22–29. Mueller, E.L., M.M. Weise, L.C. Rado, and T.J. Case, “Effects of Red Bull on Wingate Testing of College Aged Students,” Journal of Undergraduate Kinesiology Research, Vol. 2, No. 2, 2007, pp. 12–18. Mueller, F.O., et al., “Pharmacokinetics of Temazepam After Day-time and Night-time Oral Administration,” European Journal of Clinical Pharmacology, Vol. 1987, 33, pp. 211–214. Mumford, G.K., et al., “Absorption Rate of Methylxanthines Following Capsules, Cola and Chocolate,” European Jour- nal of Clinical Pharmacology, Vol. 51, 1996, pp. 319–325. Nehlig, A., “Are We Dependent Upon Coffee and Caffeine?: A Review on Human and Animal Data,” Neuroscience Biobehavioral Review, Vol. 23, 1999, pp. 563–576. Neri, D.F., S.A. Shappell, and C.A. DeJohn, “Simulated Sustained Flight Operations and Performance, Part 1: Effects of Fatigue,” Military Psychology, Vol. 4, No. 3, 1992, pp. 137–155. Neuteboom, W. and P.G.M. Zweipfenning, “Driving and the Combined Use of Drugs and Alcohol in the Netherlands,” Forensic Science International, Vol. 25, No. 2, 1984, pp. 93–104. Neutel, C.I., “Risk of Traffic Accident Injury After a Pre- scription for a Benzodiazepine,” Annals of Epidemiology, Vol. 5, 1995, pp. 239–244. Newsholme, E. and G. Hardy, “Supplementation of Diets with Nutritional Pharmaceuticals,” Nutrition, Vol. 13, 1997, pp. 837–839. Nicholson, A.N., “Long-range Air Capability and the South Atlantic Campaign,” Aviation, Space, and Environmental Medicine, Vol. 55, 1984, pp. 269–270. Nicholson, A.N. and B.M. Stone, “Performance Studies with the H1-Histamine Receptor Antihistamines, Astemizole and Terfenadine,” British Journal of Clinical Pharmacology, Vol. 13, 1982, pp. 199–202. Nicholson, A.N. and B.M. Stone, Sleep and Wakefulness Handbook for Flight Medical Officers, NATO Advisory

119 Group for Aerospace Research and Development, Neuilly- sur-Seine, France, 1982. Nicholson, A.N., B.M. Stone, and P.A. Pascoe, “Efficacy of Some Benzodiazepines for Day-time Sleep,” British Journal of Clinical Pharmacology, Vol. 10, 1980, pp. 459–463. Nicholson, A.N., P.A. Pascoe, M.B. Spencer, B.M. Stone, T.A. Roehrs, and T. Roth, “Sleep After Transmerdian Flights,” Lancet, Vol. 2, 1986, pp. 1205–1208. Nicholson, A.N., B.M. Stone, C. Turner, and S.L. Mills, “Antihistamines and Aircrew: Usefulness of Fexofenadine,” Aviation, Space and Environmental Medicine, Vol. 71, 2000, pp. 2–6. Noble, S., H.D. Langtry, and H.M. Lamb, “Zopiclone: An Update of Its Pharmacology, Clinical Efficacy and Toler- ability in the Treatment of Insomnia,” Drugs, Vol. 55, No. 2, 1998, pp. 277–302. Nybo, L., “CNS Fatigue and Prolonged Exercise: Effect of Glucose Supplementation,” Medicine and Science in Sports and Exercise, Vol. 35, No. 4, 2003, pp. 589–594. O’Hanlon, J.F., “Antihistamines and Driving Safety,” Cutis, Vol. 42, No. 4A, 1988, pp. 10–13. O’Hanlon, J.F., et al., “Anxiolytics’ Effects on the Actual Driving Performance of Patients and Healthy Volunteers in a Standardized Test: An Integration of Three Studies,” Neuropsychobiology, Vol. 31, 1995, pp. 81–88. O’Leary, D.S., et al., “Acute Marijuana Effects on rCBF and Cognition: A PET Study,” NeuroReport, Vol. 11, 2000, pp. 383–384. O’Neill, W.M., G.W. Hanks, P. Simpson, M.T. Fallon, E. Jenkins, and K. Sesnes, “The Cognitive and Psychomotor Effects of Morphine in Healthy Subjects: A Randomized Controlled Trial of Repeated (Four) Oral Doss of Dextro- propoxyphene, Morphine, Lorazepam, and Placebo,” Pain, Vol. 85, 2000, pp. 209–215. Palaminteri, R. and G. Narbonne, “Safety Profile of Zolpidem,” In: Imidazopyridines in Sleep Disorders, J.P. Sauvanet, S.Z. Langer, and P.L. Morselli, Eds., Raven Press, New York, N.Y., 1992, pp. 351–360. Parrott, A.C., “Assessment of Psychological Performance in Applied Situations,” In: Human Psychopharmacology: Measures and Methods, Vol. 1, I. Hindmarch, and P.D. Stoner, Eds., Wiley and Sons, Chichester, U.K., 1987, pp. 93–112. Parrott, A.C., “Performance Tests in Human Psychopharma- cology (1): Test Reliability and Standardization,” Human Psychopharmacology, Vol. 6, 1991, pp. 1–9. Parrott, A.C., “Performance Tests in Human Psychopharma- cology (2): Content Validity, Criterion Validity, and Face Validity,” Human Psychopharmacology, Vol. 6, 1991, pp. 91–98. Parrott, A.C., “Performance Tests in Human Psychopharma- cology (3): Construct Validity and Test Interpretation,” Human Psychopharmacology, Vol. 6, 1991, pp. 197–207. Patat, A., et al., “Lack of Interaction Between Two Anti- histamines, Mizolastine and Cetirizine, and Ethanol in Psychomotor and Driving Performance in Healthy Subjects,” European Journal of Clinical Pharmacology, Vol. 48, 1995, pp. 143–150. Patwardhan, R.V., P.V. Desmond, R.F. Johnson, and S. Schenker, “Impaired Elimination of Caffeine by Oral Contraceptive Steroids,” Journal of Lab Clinical Medicine, Vol. 95, 1980, pp. 603–608. Pechadre, J.C., D. Vernay, J.F. Trolese, M. Bloom, P. Dupont, and J.P. Rihoux, “Comparison of the Central and Periph- eral Effects of Cetirizine and Terfenadine,” European Journal of Pharmacology, Vol. 35, 1988, pp. 255–259. Pechadre, J.C., P. Beudin, A. Eschalier, J.F. Trolese, and J.P. Rihoux, “A Comparison of Central and Peripheral Effects of Cetirizine and Loratadine,” Journal of International Medical Research, Vol. 19, 1991, pp. 289–295. Pei Chan, T. and R. Rosenstein, “Influence of Alcohol and Dramamine, Alone and in Combination, on Psycho- motor Performance,” Aerospace Medicine, Vol. 38, 1967, pp. 818–821. Physicians Desk Reference for Herbal Medicines, Medical Economics, Montvale, N.J., 1998, pp. 1015–1016. Pierpaoli, W., W. Regelson, and C. Colman, “The Melatonin Miracle: Nature’s Age Reversing, Disease Fighting, Sex Enhancing Hormone,” Simon and Schuster, New York, N.Y., 1995. Pinto, L.R. and S. Tufik, “Melatonin: Nature’s Mysterious Sleep Chemical,” Sleep Review, Jan.–Feb. 2006 (on-line journal for sleep specialists) [Online]. Available: http:// www.sleepreviewmag.com/issues/articles/2006-01_01.asp. Piscitelli, S.C., A.H. Burstein, D. Chaitt, R.M. Alfaro, and J. Fallon, “Indinavir Concentrations and St. John’s Wort,” Lancet, Vol. 355, 2000, pp. 547–548. Porcu, S., A. Bellatreccia, M. Ferrara, and M. Casagrande, “Performance Ability to Stay Awake, and Tendency to Fall Asleep During the Night After a Diurnal Sleep with Temazepam or Placebo,” Sleep, Vol. 20, 1997, pp. 535–541. Portas, C.M., B. Bjorvatn, and R. Ursin, “Serotonin and the Sleep/Wake Cycle: Special Emphasis on Microdialysis Studies,” Progress in Neurobiology, Vol. 60, 2000, pp. 13–35. Ramaekers, J.G., M.M. Uiterwijk, and J.F. O’Hanlon, “Effects of Loratadine and Cetirizine on Actual Driving and Psychometric Test Performance and EEG During Driving,” European Journal of Clinical Pharmacology, Vol. 42, 1992, pp. 363–369. Rapoport, J.L., M.S. Buchsbaum, H. Weingartner, T.P. Zahn, C. Ludlow, and E.J. Mikkelsen, “Dextroamphetamine: Its Cognitive and Behavioral Effects in Normal and Hyper- active Boys and Men,” Archives of General Psychiatry, Vol. 37, 1980, pp. 933–943. Ray, W.A., R.L. Fought, and M.D. Decker, “Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers,” American Journal of Epidemiology, Vol. 136, 1992, pp. 873–883. Read, M.H., and S.L. McGuffin, “The Effect of B-Complex Supplementation on Endurance Performance,” Journal of Sports Medicine, Vol. 23, 1983, p. 178.

Rees, K., D. Allen, and M. Lader, “The Influences of Age and Caffeine on Psychomotor and Cognitive Function,” Psychopharmacology, Vol. 145, 1999, pp. 181–188. Renaud, A.M. and Y. Connier, “Acute Effects of Marijuana Smoking on Maximal Exercise Performance,” Medical Science and Sports Exercise, Vol. 18, 1986, pp. 685–689. Reyner, I.A. and J.A. Horne, “Early Morning Driver Sleepiness: Effectiveness of 200 mg Caffeine,” Psychophysiology, Vol. 37, 2000, pp. 251–256. Riccio, C.A., J.J. Waldrop, C.R. Reynolds, and P. Lowe, “Effects of Stimulants on the Continuous Performance Test (CPT): Implications for CPT Use and Interpretation,” Journal of Neuropsychiatry and Clinical Neuroscience, Vol. 13, No. 3, 2001, pp. 326–335. Riedal, W.J. and B.L. Jorissen, “Nutrients, Age and Cogni- tive Function,” Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 1, No. 6, 1998, pp. 579–585. Roehrs, T., E. Burduvali, A. Bonahoom, C. Drake, and T. Roth, “Ethanol and Sleep Loss: A Dose Comparison of Impairing Effects,” Sleep, Vol. 26, 2003, pp. 981–985. Rogers, P. and C. Demoncourt, “Regular Caffeine Con- sumption: A Balance of Adverse and Beneficial Effects for Mood and Psychomotor Performance,” Pharma- cology, Biochemistry and Behavior, Vol. 59, 1998, pp. 1039–1045. Rohrbugh, J.J., J.M. Stapleton, R. Parasuraman, H. Frowein, M.J. Eckardt, and M. Linnoila, “Alcohol Intoxication in Humans: Effects on Vigilance Performance,” Alcohol, Supplement 1, 1987, pp. 97–102. Rombaut, N.E.I. and I. Hindmarch, “Psychometric Aspects of Antihistamines: A Review,” Human Psychopharmacology, Vol. 9, 1994, pp. 157–169. Roth, T. and T. Roehrs, “A Review of the Safety Profiles of Benzodiazepine Hypnotics,” Journal of Clinical Psychiatry, Vol. 52, No. 9 (Supplement), 1991, pp. 38–47. Roth, T., P. Piccione, P. Sallis, M. Kramer, and M. Kaffeman, “Effects of Temazepam, Flurazepam and Quinalbarbi- tone on Sleep: Psychomotor and Cognitive Function,” British Journal of Clinical Pharmacology, Vol. 8, 1979, pp. 47S–54S. Roth, T., T. Roehrs, G. Koshorek, J. Sicklesteel, and F. Zorick, “Sedative Effects of Antihistamines,” Journal of Allergy and Clinical Immunology, Vol. 80, 1987, pp. 94–98. Rugg, G.H, and C.S. Smith, “A Pharmacological Study of the Active Principles of Passiflora Incarnata,” Journal of the American Pharmaceutical Association, Vol. 29, 1940, pp. 245–249. Sahaklan, B. and S. Morein-Zamir, “Professor’s Little Helper: Commentary,” Nature, Vol. 450, 2007, pp. 1157–1159. Salmun, L.M., D. Gates, M. Scharf, L. Greiding, F. Ramon, and K. Heithoff, “Loratadine Versus Cetirizine: Assessment of Somnolence and Motivation During Workday,” Clinical Therapy, Vol. 22, 2000, pp. 573–582. Sanger, D.J., G. Perrault, E. Morel, D. Joly, and B. Zivkovic, “The Behavioral Profile of Zolpidem, a Novel Hypnotic Drug of Imidazopyridine Structure,” Physiological Behav- ior, Vol. 41, 1987, pp. 235–240. 120 Sarter, M., J. Hagan, and P. Dudchenko, “Behavioral Screen- ing for Cognition Enhancers: From Indiscriminate to Valid Testing, Part I,” Psychopharmacology, Vol. 107, 1992, pp. 144–159. Schmedtje, J., C. Oman, R. Letz, and E. Baker, “Effects of Scopolamine and Dextroamphetamine on Human Perfor- mance,” Aviation, Space, and Environmental Medicine, Vol. 59, 1988, pp. 407–410. Schultz, V., R. Hansel, and V. Tyler, Rational Pyytotherapy: A Physician’s Guide to Herbal Medicine, 3rd ed., Springer Press, Berlin, Germany, 1998, pp. 74–75. Schweitzer, P.K., M.J. Muehlbach, and J.K. Walsh, “Sleepiness and Performance During Three-day Admin- istration of Cetirizine or Diphenhydramine,” Journal of Allergy and Clinical Immunology, Vol. 94, 1994, pp. 716–724. Schwilke, F.W., S. Dos Santos, and B.K. Logan, “Changing Patterns of Drug and Alcohol Use in Fatally Injured Drivers in Washington State,” Journal of Forensic Science, Vol. 51, 2006, pp. 1191–1198. Segura, R. and J.L. Ventura, “Effect of L-Tryptophan Supple- mentation on Exercise Performance,” International Journal of Sports Medicine, Vol. 9, 1988, pp. 301–351. Seidel, W.F., S. Cohen, N. Bliwise, and W.C. Dement, “Cetirizine Effects on Objective Measures of Daytime Sleepiness and Performance,” Annals of Allergy, Vol. 59, 1987, pp. 58–62. Seidel, W.F., S. Cohen, N.G. Bliwise, and W.C. Dement, “Direct Measurement of Daytime Sleepiness after Admin- istration of Cetirizine and Hydroxyzine with a Stan- dardized Electroencephalographic Assessment,” Journal of Allergy and Clinical Immunology, Vol. 86, 1990, pp. 1029–1033. Senechal, P.K., “Flight Surgeon Support of Combat Operations at RAF Upper Heyford,” Aviation, Space and Environ- mental Medicine, Vol. 59, 1988, pp. 776–777. Seppala, T., K. Korttila, S. Hakkinen, and M. Linnoila, “Residual Effects and Skills Related to Driving After a Single Oral Administration of Diazepam, Medazepam or Lorazepam,” British Journal of Clinical Pharmacology, Vol. 3, 1976, pp. 831–841. Sevy, S., et al., “Double-blind, Placebo-controlled Study of Modafinal for Fatigue and Cognition in Schizophrenia Patients Treated with Psychotropic Medications,” Journal of Clinical Psychiatry, Vol. 66, 2005, pp. 839–843. Shamsi, Z. and I. Hindmarch, “Sedation and Antihistamines: A Review of Inter-drug Differences Using Proportional Impairment Ratios,” Human Psychopharmacology and Clinical Experimentation, Vol. 15, 2000, pp. S3–S30. Shamsi, Z., S. Kimber, and I. Hindmarch, “An Investigation into the Effects of Cetirizine on Cognitive Function and Psychomotor Performance in Healthy Volunteers,” Euro- pean Journal of Clinical Pharmacology, Vol. 56, 2001, pp. 865–871. Shappell, S.A., D.F. Neri, and C.A. De John, “Simulated Sustained Flight Operations and Performance, Part 2: Effects

121 of Dextro-methamphetamine,” Military Psychology, Vol. 4, No. 4, 1992, pp. 267–287. Simons, F.E.R., “H1 Receptor Antagonists: Comparative Tolerability and Safety,” Drug Safety, Vol. 10, 1994, pp. 350–380. Simons, F.E.R., T.G. Fraser, J.D. Reggin, and K.J. Simons, “Comparison of the Central Nervous System Effects Produced by Six H1-Receptor Antagonists,” Clinical Experimental Allergy, Vol. 26, 1996, pp. 1092–1097. Skene, D.J and J. Arnedt, “Human Circadian Rhythms: Physiological and Therapeutic Relevance of Light and Melatonin,” Annals of Clinical Biochemistry, Vol. 43, 2006, pp. 344–353. Skurtveit, S.A., S. Christophersen, M. Grung, and J. Morland, “Increased Mortality Among Previously Apprehended Drunken and Drugged Drivers,” Drug and Alcohol Depen- dency, Vol. 68, 2002, pp. 143–150. Slavin, J.L., “Amino Acid Supplementation: Beneficial or Risky?” The Physician Sports Medicine, Vol. 16, No. 3, 1988, p. 221. Starmer, G.A., et al., “Drug Usage by Australian Drivers,” In: Alcohol, Drugs and Traffic Safety—T’97, Vol. III, C. Mercier-Guyon, Ed., Annecy France, CERT, 1997, pp. 1135–1141. Steadward, R.D. and M. Singh, “The Effects of Smoking Marijuana on Physical Performance,” Medical Science and Sports Exercise, Vol. 47, 1975, pp. 192–195. Stensrud, T., et al., “L-tryptophan Supplementation Does Not Improve Running Performance,” International Journal of Sports Medicine, Vol. 13, 1992, pp. 481–485. Stepansik, E.J. and J.K. Wyatt, “Use of Sleep Hygiene in the Treatment of Insomnia,” Sleep Medicine Review, Vol. 7, 2003, pp. 215–225. Stewart, K., “Overview and Summary,” In: Transportation Research Circular E-096: Drugs and Traffic: A Symposium. Transportation Research Board Committee on Alcohol, and Other Drugs, Woods Hole, Mass., June 20–21, 2005, Transportation Research Board of the National Academies, Washington, D.C., 2005, pp. 6–14. Stone, B.M. and C. Turner, “Promoting Sleep in Shift Workers and Intercontinental Travelers,” Chronobiology Inter- national, Vol. 14, 1997, pp. 133–143. Subhan, Z. and I. Hindmarch, “The Psychopharmacological Effects of Ginkgo Biloba Extract in Normal Healthy Volunteers,” International Journal of Clinical Pharmaco- logical Research, Vol. 4, No. 2, 1984, pp. 89–93. Suhner, A., P. Schlagenhauf, I. Hofer, R. Johnson, A. Tschopp, and R. Steffen, “Effectiveness and Tolerability of Melatonin and Zolpidem for the Alleviation of Jet Lag,” Aviation, Space, and Environmental Medicine, Vol. 72, 2001, pp. 638–646. Sutton, L.R. and I. Paegle, “The Drug Impaired Driver: Detection and Forensic Specimen Analysis,” Blutalkohol, Vol. 29, No. 2, 1992, pp. 134–138. Tagawa, M., et al., “Relationship Between Effects of Alcohol on Psychomotor Performances and Blood Alcohol Con- centrations,” Japanese Journal of Pharmacology, Vol. 83, 2000, pp. 253–260. Takahashi, H., A. Ishida-Yamamoto, and H. Iizuka, “Effects of Bepotastine, Cetirizine, Fexofenadine, and Olopatadine on Histamine-induced Wheal-and-Flare Response, Sedation, and Psychomotor Performance,” Clinical Experimental Dermatology, Vol. 29, 2004, pp. 526–532. Tashiro, M., et al., “Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H1-receptor Occupancy Using 11C-doxepin Positron Emission Tomog- raphy,” Journal of Clinical Pharmacology, Vol. 44, 2004, pp. 890–900. Tharion, W.J., et al., The Use of Caffeine to Enhance Cognitive Performance, Reaction Time, Vigilance, Rifle Marksmanship and Mood States in Sleep-deprived Navy SEALS (BUD/S) Trainees, USARIEM Technical Report No. T98-4, U.S. Army Research Institute of Environmental Medicine, Natick, Mass., 1997. Theunissen, E.L., A. Vermeeren, A.C. Van Oers, I. Van Maris, and J.G. Ramaekers, “A Dose-ranging Study of the Effects of Mequitazine on Actual Driving, Memory and Psycho- motor Performance as Compared to Dexchlorpheniramine, Cetirizine and Placebo,” Clinical Experimental Allergy, Vol. 34, No. 2, 2004, pp. 250–258. Theunissen, E.L., L.M. Jonkman, K.P.C. Kuypers, and J.G. Ramaekers, “A Combined Neurophysiological and Behav- ioural Study into the Stimulating Effects of Fexofenadine on Performance,” Journal of Psychopharmacology, Vol. 20, 2006, pp. 496–505. Theunissen, E.L., A. Vermeeren, and J.G. Ramaekers, “Repeated-dose Effects of Mequitazine, Cetirizine and Dexchlorpheniramine on Driving and Psychomotor Per- formance,” British Journal of Clinical Pharmacology, Vol. 61, 2006, pp. 79–86. Theunissen, E.L., M.J. Van Kroonenburgh, J.A. Van Deursen, C. Blom-Coenjaerts, and J.G. Ramaekers, “Stimulating Effects of the Antihistamine Fexofenadine: Testing the Dopamine Transporter Hypothesis,” Psychopharmacology, Vol. 187, 2006, pp. 95–102. Tikuisis, P., A.A. Keefe, T.M. McLellan, and G. Kamimori, “Caffeine Restores Engagement Speed But Not Shooting Precision Following 22 h of Active Wakefulness,” Aviation, Space, and Environmental Medicine, Vol. 75, No. 9, 2004, pp. 771–776. Touitou, Y. and A. Bogdan, “Promoting Adjustment of the Sleep-Wake Cycle by Chronobiotics,” Physiological Behavior, Vol. 90, 2007, pp. 294–300. Tregar, S.J. and C. Akafomo, “Expert Medical Panel Commentary and Recommendations: Licit Schedule II Drug Use and Commercial Motor Vehicle Driver Safety,” N. Hartenbaum presentation to DOT’s Federal Motor Carrier Safety Administration, Dec. 9, 2006, FMSCA, U.S. Department of Transportation, Washington, D.C. [Online]. Available: www.fmcsa.dot.gov. Turner, D.C., T.W. Robbins, L. Clark, A.R. Aron, J. Dowson, and B.J. Sahakian, “Cognitive Enhancing Effects of

122 Modafinil in Healthy Volunteers,” Psychopharmacology, Vol. 165, 2003, pp. 260–269. Turner, D.C., L. Clark, E. Pomarol-Clotet, P. McKenna, T.W. Robbins, and B.J. Sahakian, “Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia,” Neuropsychopharmacology, Vol. 29, 2004, pp. 1363–1373. Uchiumi, M., S. Isawa, M. Suzuki, and M. Murasaki, “The Effects of Zolpidem and Zopiclone on Daytime Sleepiness and Psychomotor Performance,” Nihon Shinkei Seishin Yakurigaku Zasshi, the Japanese Journal of Psychopharma- cology, Vol. 20, No. 3, 2000, pp. 123–130. U.S. Navy, Performance Maintenance During Continuous Flight Operations: A Guidebook for Flight Surgeons, NAVMED-P-6410, Naval Strike and Air Warfare Cen- ter, Fallon, Nev., Jan. 1, 2000. Vakulin, A., et al., “Effects of Moderate Sleep Deprivation and Low Dose Alcohol on Driving Simulator Performance and Perception in Young Men,” Sleep, Vol. 30, No. 10, 2007, pp. 1327–1333. Van den Heuvel, C.J., S.A. Ferguson, M.M. Macchi, and D. Dawson, “Melatonin as a Hypnotic: Con,” Sleep Medicine Review, Vol. 9, 2005, pp. 71–80. Vermeeren, A., J.G. Ramaekers, and J.F. O’Hanlon, “Effects of Emedastine and Cetirizine, Alone and with Alcohol, on Actual Driving of Males and Females,” Journal of Psycho- pharmacology, Vol. 16, 2002, pp. 57–64. Verster, J.C., et al., “Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Abil- ity, Memory Functions, and Psychomotor Performance,” Journal of Clinical Psychopharmacology, Vol. 22, No. 6, 2002, pp. 576–583. Verstraete, A.G., “Which Medicinal Drugs Impair Driving Performance? An Overview of the European Experience,” In: Proceedings of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) Meeting, Stockholm, Sweden, May 2000. Volkow, N.D., “Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task,” PLoS ONE, Vol. 3, No. 4, 2008, p. e2017. Wagenmakers, A.J., “Amino Acid Supplements to Improve Athletic Performance,” Current Opinion on Clinical Nutri- tional Metabolism Care, Vol. 2, No. 6, 1996, pp. 539–544. Wagner, J.C., “Enhancement of Athletic Performance with Drugs: An Overview,” Sports Medicine, Vol. 12, 1991, pp. 250–265. Walker, J., et al., “Chronic Opiods Use Is a Risk Factor for the Development of Central Sleep Apnea and Ataxic Breathing,” Journal of Clinical Sleep Medicine, Vol. 3, No. 5, 2007, pp. 455–461. Walker, T.B., U. Balldin, J. Fischer, W. Storm, and G.L. Warren, “Acceleration Tolerance after Ingestion of a Com- mercial Energy Drink,” Aviation, Space, and Environmen- tal Medicine, Vol. 81, 2010, pp. 1100–1106. Wallace, M.B., J. Lim, A. Cutter, and L. Bucci, “Effects of Dehydroepiandrosterone vs. Androstenedione Supple- mentation in Men,” Medical Science and Sports Exercise, Vol. 31, No. 12, 1999, pp. 1788–1792. Walsh, J.K., M.J. Muehlbach, and P.K. Schweitzer, “Simulated Assembly Line Performance Following Ingestion of Cetirizine or Hydroxyzine,” Annals of Allergy, Vol. 69, 1992, pp. 195–200. Walsh, J.M., J.J. De Gier, A.S. Christopherson, and A.G. Verstraete, “Drugs and Driving,” Traffic Injury Prevention, Vol. 5, 2004, pp. 241–253. Wansbrough, P.R.I., Cognitive Enhancers and Their Poten- tial Use in Military Operations, DERA/CHS/PP5/CR/ 9800371/1.0, Minister of Defence Evaluation and Research Agency (DERA), Farnborough, Hampshire, U.K., Jan. 1998, Weight, L.M., K.H. Myburgh, and T.D. Noakes, “Vitamin and Mineral Supplementation: Effect on Running Perfor- mance of Trained Athletes,” American Journal of Clinical Nutrition, Vol. 47, 1988, pp. 192–195. Weiss, B. and V.G. Laties, “Enhancement of Human Perfor- mance by Caffeine and the Amphetamines,” Pharmaco- logical Review, 1962, Vol. 14, pp. 1–36. Wesnes, K. and D.M. Warburton, “A Comparison of Temazepam and Flurazepam in Terms of Sleep Quality and Residual Changes in Performance,” Neuropsychobiology, Vol. 11, 1984, pp. 255–259. Whitsett, T.L., C.V. Manion, and H.D. Christensen, “Cardio- vascular Effects of Coffee and Caffeine,” American Journal of Cardiology, Vol. 53, 1984, pp. 918–922. Williams, D., C.E. Englund, A.A. Sucec, and M.D. Overson, “Effects of Chemical Protective Clothing, Exercise, and Diphenhydramine on Cognitive Performance During Sleep Deprivation,” Military Psychology, Vol. 9, 1997, pp. 329–358. Williamson, A., “Predictors of Psychostimulant Use by Long-distance Truck Drivers,” American Journal of Epidemiology, Vol. 166, 2007, pp. 1320–1326. Williamson, A.M., A.M. Feyer, C. Coumarelos, and T. Jenkins, Strategies to Combat Fatigue in the Long Distance Road Transport Industry, Stage 1: The Industry Perspective, FORS Report CR-108, Federal Office of Road Safety, Canberra, Australia, 1992. Williamson, A.M., et al., Driver Fatigue: A Survey of Long Distance Heavy Vehicle Drivers in Australia, ATSB Report No. CR-198, Australian Transportation Safety Bureau, Canberra, 2001. Winfield, R., “The Use of Benzedrine to Overcome Fatigue on Operational Flights in Coastal Command. United Kingdom: Flying Personnel Research Committee [Defense Technical Information Center Report Number: AD-B953285],” Oct. 1941. Wing, Y.K., “Herbal Treatment of Insomnia,” Hong Kong Medical Journal, Vol. 7, 2001, pp. 392–402. Wirz-Justice, A. and S.M. Armstrong, “Melatonin: Nature’s Soporific?” Journal of Sleep Research, Vol. 5, 1996, pp. 137–141. Witek, T.J., D.A. Canestrari, R.D. Miller, J.Y. Yang, and D.K. Rikere, “Characterization of Daytime Sleepiness and Psychomotor Performance Following H1 Receptor Antagonists,” Annals of Allergy Asthma Immunology, Vol. 74, 1995, pp. 419–426.

123 Wolfe, R., “Protein Supplements and Exercise,” American Journal of Clinical Nutrition, Vol. 72, 2000, pp. 551S–557S. Wurtman, R.J. and M.C. Lewis, “Exercise, Plasma Com- position, and Neurotransmission,” Medicine and Sports Science, Vol. 32, 1991, pp. 94–109. Wyatt, J.K., C. Cajochen, A. Ritz-DeCecco, C.A. Czeisler, and D.J. Dijk, “Low-dose Repeated Caffeine Administration for Circadian-Phase-Dependent Performance Degradation During Extended Wakefulness,” Sleep, Vol. 27, No. 3, 2004, pp. 374–381. Yeomans, M.R., T. Ripley, L.H. Davies, J.M. Rusted, and P.J. Rogers, “Effects of Caffeine on Performance and Mood Depend on the Level of Caffeine Abstinence,” Psycho- pharmacology, Vol. 164, No. 3, 2002, pp. 241–249. Yesavage, J.A. and V.O. Leirer, “Hangover Effects on Aircraft Pilots 14 Hours After Alcohol Ingestion: A Preliminary Report,” American Journal of Psychiatry, Vol. 143, 1986, pp. 1546–1550. Zhdanova, I.V., “Melatonin as a Hypnotic: Pro,” Sleep Medicine Review, Vol. 9, 2005, pp. 51–65. Zwicker, T., D. Preusser, and R. Compton, “Risks Posed by Drugs in Traffic: Incidence and Crash Risk of Drug Impaired Driving,” In: Transportation Research Circu- lar No. E-C096: Drugs and Traffic: A Symposium, Trans- portation Research Board Committee on Alcohol and Other Drugs, Woods Hole, Mass., June 20–21, 2005, Trans- portation Research Board of the National Academies, Washington, D.C., 2005, pp. 27–36.